Literature DB >> 31407855

Neurocritical care monitoring of encephalopathic children with acute liver failure: A systematic review.

Adam Hunt1, Robert C Tasker2, Akash Deep3.   

Abstract

Research on non-invasive neuromonitoring specific to PALF is limited. This systematic review identifies and synthesis the existing literature on non-invasive approaches to monitoring for neurological sequelae in patients with PALF. A series of literature searches were performed to identify all publications pertaining to five different non-invasive neuromonitoring modalities, in line with PRISMA guidelines. Each modality was selected on the basis of its potential for direct or indirect measurement of cerebral perfusion; studies on electroencephalographic monitoring were therefore not sought. Data were recorded on study design, patient population, comparator groups, and outcomes. A preponderance of observational studies was observed, most with a small sample size. Few incorporated direct comparisons of different modalities; in particular, comparison to invasive intracranial pressure monitoring was largely lacking. The integration of current evidence is considered in the context of the clinically significant distinctions between pediatric and adult ALF, as well as the implications for planning of future investigations to best support the evidence-based clinical care of these patients.
© 2019 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2019        PMID: 31407855     DOI: 10.1111/petr.13556

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  2 in total

1.  Non-transplant options in paediatric acute liver failure-what is new?

Authors:  Akash Deep; Satoshi Nagakawa; Pierre Tissieres
Journal:  Intensive Care Med       Date:  2022-01       Impact factor: 17.440

2.  Outbreak of hepatitis in children: clinical course of children with acute liver failure admitted to the intensive care unit.

Authors:  Akash Deep; Anil Dhawan; Tassos Grammatikopoulos; Nigel Heaton; Anita Verma
Journal:  Intensive Care Med       Date:  2022-06-10       Impact factor: 41.787

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.